Live Breaking News & Updates on Joseph Sipalan

Stay updated with breaking news from Joseph sipalan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UPDATE 2-China's Sinovac defends COVID-19 vaccine after disappointing Brazil data


Had reported 78% efficacy in mild-to-severe cases
Chairman says results are good around the world
Malaysia and Singapore seeking more data (Recasts to add details from Sinovac executive, Thailand and Singapore, and background)
KUALA LUMPUR/SINGAPORE, Jan 13 (Reuters) - China’s Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine on Wednesday, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced.
The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on “very mild” cases, researchers said on Tuesday.
Last week, they said the vaccine, called CoronaVac, showed 78% efficacy against “mild-to-severe” cases. ....

Kuala Lumpur , Krung Thep Mahanakhon , Chen Lin , Jakarta Raya , Panarat Thepgumpanat , Stanley Widianto , Joseph Sipalan , Sinovac Coronavac , Ed Davies , Pharmaniaga Bhd , Mark Potter , Roxanne Liu , Chayut Setboonsarng , Joko Widodo , Sinovac Biotech , Biotech Chairman Yin Weidong , President Joko Widodo , Yew Lun Tian , Sayantani Ghosh Editing , Coronavirus Malaysia Update 2 , Asean Countries , Asia Pacific , Corporate Events , Biopharmaceuticals Trbc Level 5 , Company News , Communicable Diseases ,